Literature DB >> 22641099

Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.

María Victoria García-Mediavilla1, Sandra Pisonero-Vaquero, Elena Lima-Cabello, Ignacio Benedicto, Pedro Lorenzo Majano, Francisco Jorquera, Javier González-Gallego, Sonia Sánchez-Campos.   

Abstract

Molecular mechanisms contributing to hepatitis C virus (HCV)-associated steatosis are not well established, although HCV gene expression has been shown to alter host cell cholesterol/lipid metabolism. As liver X receptors (LXRs) play a role as key modulators of metabolism signaling in the development of steatosis, we aimed to investigate in an HCV in vitro model the effect of HCV NS5A protein, core protein, and viral replication on the intracellular lipid accumulation and the LXRα-regulated expression of lipogenic genes. The effects of LXRα siRNA or agonist GW3965 treatment on lipogenesis and HCV replication capacity in our HCV replicon system were also examined. NS5A- and core-expressing cells and replicon-containing cells exhibited an increase of lipid accumulation by inducing the gene expression and the transcriptional activity of LXRα, and leading to an increased expression of its lipogenic target genes sterol regulatory element binding protein-1c, peroxisome proliferator-activated receptor-γ, and fatty acid synthase. Transcriptional induction by NS5A protein, core protein, and viral replication occurred via LXR response element activation in the lipogenic gene promoter. No physical association between HCV proteins and LXRα was observed, whereas NS5A and core proteins indirectly upregulated LXRα through the phosphatidylinositol 3-kinase pathway. Finally, it was found that LXRα knockdown or agonist-mediated LXRα induction directly regulated HCV-induced lipogenesis and HCV replication efficiency in replicon-containing cells. Combined, our data suggest that LXRα-mediated regulation of lipogenesis by core and NS5A proteins may contribute to HCV-induced liver steatosis and to the efficient replication of HCV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641099     DOI: 10.1038/labinvest.2012.88

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  MicroRNAs regulate the immunometabolic response to viral infection in the liver.

Authors:  Ragunath Singaravelu; Shifawn O'Hara; Daniel M Jones; Ran Chen; Nathan G Taylor; Prashanth Srinivasan; Curtis Quan; Dominic G Roy; Rineke H Steenbergen; Anil Kumar; Rodney K Lyn; Dennis Özcelik; Yanouchka Rouleau; My-Anh Nguyen; Katey J Rayner; Tom C Hobman; David Lorne Tyrrell; Rodney S Russell; John Paul Pezacki
Journal:  Nat Chem Biol       Date:  2015-10-19       Impact factor: 15.040

2.  Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.

Authors:  Syo Nakajima; Koichi Watashi; Hirofumi Ohashi; Shinji Kamisuki; Jesus Izaguirre-Carbonell; Andrew Tae-Jun Kwon; Harukazu Suzuki; Michiyo Kataoka; Senko Tsukuda; Maiko Okada; Meng Ling Moi; Toshifumi Takeuchi; Minetaro Arita; Ryosuke Suzuki; Hideki Aizaki; Takanobu Kato; Tadaki Suzuki; Hideki Hasegawa; Tomohiko Takasaki; Fumio Sugawara; Takaji Wakita
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

Review 3.  Liver steatosis in hepatitis C patients.

Authors:  Emilio González-Reimers; Geraldine Quintero-Platt; Melchor Rodríguez-Gaspar; Remedios Alemán-Valls; Onán Pérez-Hernández; Francisco Santolaria-Fernández
Journal:  World J Hepatol       Date:  2015-06-08

4.  Regulation of Hepatitis C Virus Infection by Cellular Retinoic Acid Binding Proteins through the Modulation of Lipid Droplet Abundance.

Authors:  Bo-Ram Bang; Meng Li; Kuen-Nan Tsai; Haruyo Aoyagi; Shin-Ae Lee; Keigo Machida; Hideki Aizaki; Jae U Jung; Jing-Hsiung James Ou; Takeshi Saito
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 5.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 6.  Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

Authors:  Swetha Rudraiah; Xi Zhang; Li Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

7.  Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin.

Authors:  Sandra Pisonero-Vaquero; María V García-Mediavilla; Francisco Jorquera; Pedro L Majano; Marta Benet; Ramiro Jover; Javier González-Gallego; Sonia Sánchez-Campos
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

8.  PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.

Authors:  Marion Peyrou; Pierluigi Ramadori; Lucie Bourgoin; Michelangelo Foti
Journal:  PPAR Res       Date:  2012-09-13       Impact factor: 4.964

9.  Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.

Authors:  Ramazan Kurt; Partha K Chandra; Fatma Aboulnasr; Rajesh Panigrahi; Pauline Ferraris; Yucel Aydin; Krzysztof Reiss; Tong Wu; Luis A Balart; Srikanta Dash
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

10.  Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis.

Authors:  Irene Crespo; Beatriz San-Miguel; Carolina Prause; Norma Marroni; María J Cuevas; Javier González-Gallego; María J Tuñón
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.